Every material Form 8-K Alphatec Holdings, Inc. has filed with the SEC since June 11, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Alphatec reported third-quarter 2026 revenue of $221 million, up 13% year-over-year, with a GAAP net loss of $5 million versus $29 million a year earlier. CEO Pat Miles said revenue fell short of the company's expectations, mainly due to lower biologics attachment, while surgical hardware and case volumes grew. The company now expects full-year 2026 total revenue of approximately $862 million and adjusted EBITDA of approximately $137 million.
Total revenue $221 million, up 13% year-over-year; surgical revenue $202 million, up 14%
GAAP net loss $5 million versus $29 million a year earlier; non-GAAP net income $15 million
Alphatec reported second-quarter 2026 revenue of $214 million, up 15% year-over-year, and a GAAP net loss of $26 million, narrower than $41 million a year earlier. The company raised its full-year 2026 adjusted EBITDA guidance to approximately $140 million from approximately $134 million and kept its revenue outlook of approximately $882 million.
Q2 2026 total revenue of $214 million, up 15% year-over-year; surgical revenue of $196 million, up 17%
GAAP net loss of $26 million in Q2 2026 versus $41 million in Q2 2025; non-GAAP net income of $11 million
Adjusted EBITDA of $36 million, or 16.8% margin, versus $23 million in Q2 2025
2026 adjusted EBITDA guidance raised to approximately $140 million from $134 million; revenue outlook of approximately $882 million reaffirmed
At its June 10, 2026 annual meeting, Alphatec Holdings stockholders approved the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan, which took effect upon approval. Stockholders also elected seven directors to one-year terms, ratified Deloitte & Touche LLP as auditor for fiscal 2026, and approved executive compensation on a non-binding advisory basis.
Equity Incentive Plan approved with 66,250,952 votes for, 28,116,490 against and 273,648 abstentions
Employee Stock Purchase Plan approved with 94,532,324 votes for, 85,516 against and 23,250 abstentions
Quorum of 118,373,608 of 153,702,057 outstanding shares, as of the April 15, 2026 record date
Non-binding say-on-pay vote: 81,927,395 for and 12,420,476 against
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Alphatec Holdings, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →